Elliot Waterman OD in N Kingstown, Rhode Island

Home Rhode Island N Kingstown

Elliot Waterman OD has Optometry as his primary medical specialty. Their primary office is: 426 Scrabbletown Rd in N Kingstown, Rhode Island. They attended New England College Of Optometry and graduated in 1985 (around 39 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Elliot D Waterman OD Office Phone and Directions

Elliot Waterman OD
426 Scrabbletown Rd
N Kingstown, Rhode Island 02852
401-295-7339

Patient Ratings
Please rate your experience with Elliot Waterman OD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 401-295-7339

Enter a starting address:

Healthcare Info for Elliot Waterman OD

Medical School: New England College Of Optometry
Graduation Year: 1985
The Primary Medical Specialty for Elliot Waterman OD is listed as: Optometry
Credentials: OD
Additional Credentials:
Approximate Years of Experience: 39
PAC (PECOS ID)#: 6204892391
NPI #: 1649378431
NPI Created On: 09/20/2006
NPI Last Updated Listed as: 07/08/2007
Primary Taxonomy Code: 152W00000X
License Number:
ODTG-397
Listed Gender: Male

Procedures, Services, Charges

Services and Procedures include:

Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits
Eye and medical examination for diagnosis and treatment, established patient
Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $77

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 792980189

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: DRY EYE

Name of Drug #1: RESTASIS MULTIDOSE

Open Associated Drug #1: 0023-5301-05